Detection of cytomegalovirus in bronchoalveolar lavage fluid from immunocompromised patients with pneumonitis by viral culture and DNA quantification.

[1]  T. Kawamatawong,et al.  A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts. , 2022, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  J. Vila,et al.  SARS-CoV-2 normalized viral loads and subgenomic RNA detection as tools for improving clinical decision-making and work reincorporation , 2021, The Journal of infectious diseases.

[3]  M. Tamm,et al.  Comparing cytomegalovirus diagnostics by cell culture and quantitative nucleic acid testing in broncho‐alveolar lavage fluids , 2020, Journal of medical virology.

[4]  T. Lazzarotto,et al.  Clinical Diagnostic Testing for Human Cytomegalovirus Infections. , 2020, The Journal of infectious diseases.

[5]  M. Tormo,et al.  Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia , 2019, Journal of Infection.

[6]  A. Limper,et al.  Cytomegalovirus (CMV) DNA quantification in bronchoalveolar lavage fluid of immunocompromised patients with CMV pneumonia , 2018, Clinical transplantation.

[7]  J. Lundgren,et al.  Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia , 2017, Transplantation.

[8]  W. Leisenring,et al.  Cytomegalovirus (CMV) DNA Quantitation in Bronchoalveolar Lavage Fluid From Hematopoietic Stem Cell Transplant Recipients With CMV Pneumonia , 2017, The Journal of infectious diseases.

[9]  J. Lee,et al.  Diagnosis of cytomegalovirus pneumonia by quantitative polymerase chain reaction using bronchial washing fluid from patients with hematologic malignancies , 2017, Oncotarget.

[10]  M. Boeckh,et al.  Reduced Mortality of Cytomegalovirus Pneumonia After Hematopoietic Cell Transplantation Due to Antiviral Therapy and Changes in Transplantation Practices. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  B. Pinsky,et al.  Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis , 2015, Open forum infectious diseases.

[12]  C. Kotton.  CMV: Prevention, Diagnosis and Therapy , 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[13]  Michael Boeckh,et al.  Cytomegalovirus: pathogen, paradigm, and puzzle. , 2011, The Journal of clinical investigation.

[14]  B. Bekele,et al.  Clinical Utility of Cytomegalovirus Viral Load in Bronchoalveolar Lavage in Lung Transplant Recipients , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[15]  G. Snell,et al.  Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients. , 2004, The Journal of infectious diseases.

[16]  S. Arrigain,et al.  Correlation between Viral Loads of Cytomegalovirus in Blood and Bronchoalveolar Lavage Specimens from Lung Transplant Recipients Determined by Histology and Immunohistochemistry , 2004, Journal of Clinical Microbiology.

[17]  N. Müller,et al.  Thin-section CT findings in 32 immunocompromised patients with cytomegalovirus pneumonia who do not have AIDS. , 2003, AJR. American journal of roentgenology.

[18]  Thomas F. Smith,et al.  Role of the Laboratory in Diagnosis and Management of Cytomegalovirus Infection in Hematopoietic Stem Cell and Solid-Organ Transplant Recipients , 2002, Journal of Clinical Microbiology.

[19]  S. Olofsson,et al.  Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients. , 2000, Chest.

[20]  J. Bourhis,et al.  Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation? , 1997, British journal of haematology.

[21]  G. Boivin,et al.  Quantitation of cytomegalovirus DNA and characterization of viral gene expression in bronchoalveolar cells of infected patients with and without pneumonitis. , 1996, The Journal of infectious diseases.

[22]  F. Brancart,et al.  Rapid diagnosis of cytomegalovirus lung infection by DNA amplification in bronchoalveolar lavages. , 1994, Molecular and cellular probes.

[23]  P. Ljungman,et al.  Cytomegalovirus excretion as a predictor of cytomegalovirus disease after marrow transplantation: importance of cytomegalovirus viremia. , 1990, The Journal of infectious diseases.

[24]  W. Drew,et al.  Comparison of conventional and shell vial cultures for detecting cytomegalovirus infection , 1990, Journal of clinical microbiology.

[25]  D. Stover,et al.  Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. , 1984, Annals of internal medicine.

[26]  V. Miller,et al.  Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials. , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.